Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CAT gets U.K. approval to begin phase II trials of novel glaucoma treatment

July 12, 1999

Allergan ciclosporin NDA up for review this month by advisory committee

July 12, 1999

Midostaurin is a promising new agent for preventing vision loss

July 9, 1999

Chiron develops novel gene therapy for degenerative retinal disorders

July 6, 1999

Interim phase I/II data presented for Lu-Tex in age-related macular degeneration

July 2, 1999

Xoma licenses use of recombinant BPI to Allergan for ophthalmic infections

June 30, 1999

Substituted imidazoles for glaucoma, pain, etc., in early development at Allergan

June 29, 1999

Daclizumab may have applications in uveitis therapy

June 25, 1999

Bausch & Lomb to collaborate on ophthalmic drug delivery technology

June 23, 1999

InSite Vision's ISV-205 achieves positive results in phase II study

June 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...